ConductScience.org, home

Paper177449

A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.

McKenzie JM and 1 other. J Clin Endocrinol Metab, 1976. Cited by 131 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease. Papers, record 177449. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/177449

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
PubMed
Journal
J Clin Endocrinol Metab
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
131
iCite
Relative citation ratio, by iCite
4.69
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McKenzie JMJ M
2Zakarija MM

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Graves DiseaseMajor topic
HyperthyroidismMajor topic
ImmunoglobulinsMajor topic
Thyroid GlandMajor topic
Animals
Cyclic AMP
Humans
Immunoglobulin G
Long-Acting Thyroid Stimulator
Mice

Source PubMed

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.

PMIDTitleJournalYearIn PapersSource
39,169,342Prognostic factors for thyroid-stimulating immunoglobulin normalization in moderate-to-severe Graves' orbitopathy: a 36-month longitudinal study.BMC Ophthalmol2024https://conductscience.org/library/papers/39169342PubMed
6,894,884Graves' hyperthyroidism and ophthalmopathy following treatment of spontaneous hypothyroidism with levothyroxine.Can Med Assoc J1981https://conductscience.org/library/papers/6894884PubMed
6,894,603The nude mouse. A possible experimental model for investigation of human thyroid tissue.J Endocrinol Invest1981https://conductscience.org/library/papers/6894603PubMed
6,801,107Familial inappropriate TSH secretion: evidence suggesting a dissociated pituitary resistance to T3 and T4.J Endocrinol Invest1981https://conductscience.org/library/papers/6801107PubMed
6,325,527Thyroid hormone secretion is more sensitive than thyroid cyclic AMP accumulation to stimulation with LATS in mice in vitro and in vivo.J Endocrinol Invest1984https://conductscience.org/library/papers/6325527PubMed
6,296,219Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies.J Endocrinol Invest1982https://conductscience.org/library/papers/6296219PubMed
6,292,912Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6292912PubMed
6,251,989Thyroid-stimulating antibody (TSab) detected in sera of Graves' patients using human thyroid cell cultures.Clin Exp Immunol1980https://conductscience.org/library/papers/6251989PubMed
6,147,408Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983.J R Coll Physicians Lond1984https://conductscience.org/library/papers/6147408PubMed
6,147,216Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.Clin Exp Immunol1984https://conductscience.org/library/papers/6147216PubMed
6,138,363Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.J Clin Invest1983https://conductscience.org/library/papers/6138363PubMed
6,132,943Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema.J Endocrinol Invest1982https://conductscience.org/library/papers/6132943PubMed
6,088,581Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.J Clin Invest1984https://conductscience.org/library/papers/6088581PubMed
2,880,683Thyroid stimulating immunoglobulin (TSI) synthesis by pokeweed mitogen (PWM) stimulated peripheral blood lymphocytes (PBL) from Graves' disease (GD) patients.Clin Exp Immunol1986https://conductscience.org/library/papers/2880683PubMed
381,768[Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)].Klin Wochenschr1979https://conductscience.org/library/papers/381768PubMed
90,689Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?J Endocrinol Invest1978https://conductscience.org/library/papers/90689PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/177449

GET https://conductscience.org/api/papers/v1/177449/authors